Resveratrol protects against neurotoxicity induced by kainic acid

Neurochemical Research

Volumn 29, Issue 11 SPEC. ISS., 2004, Pages 2105-2112

  Wang, Qun ^a   Yu, Sue ^b   Simonyi, Agnes ^b   Rottinghaus, George ^c   Sun, Grace Y ^b   Sun, Albert Y ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Antioxidants; astrocyte; excitatory neurotransmittors; Kainic acid; microglia; neuron; resveratrol

Indexed keywords

KAINIC ACID; NEUROPROTECTIVE AGENT; RESVERATROL; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; BRAIN TISSUE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; DRUG EFFICACY; HIPPOCAMPUS; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; TISSUE SECTION;

ANIMALS; BIOLOGICAL AVAILABILITY; CELL DEATH; EXCITATORY AMINO ACID AGONISTS; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; MALE; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS; VITIS SP.;

EID: 10844267380     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-004-6883-z     Document Type: Article

References (52)

1. Jellinger, K. A. and Stadelmann, C. 2000. Mechanisms of cell death in neurodegenerative disorders. J. Neural Transm. 59 (Suppl.):95-114.
2. Doble, A. 1999. The role of excitotoxicity in neurodegenerative disease: Implications for therapy. Pharmacol. Ther. 81:163-221.
3. Meldrum, B. S. 2000. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J. Nutr. 130:1007S-1015S.
4. Sun, A. Y. and Chen, Y. M. 1998. Oxidative stress and neurodegenerative disorders. J. Biomed. Sci. 5:401-414.
5. Bleakman, D. and Lodge, D. 1998. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology 37:1187-1204.
6. Sun, A. Y., Cheng, Y., and Sun, G. Y. 1992. Kainic acid-induced excitotoxicity in neurons and glial cells. Prog. Brain Res. 94:271-280.
7. Cheng, Y. and Sun, A. Y. 1994. Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons. Neurochem. Res. 19:1557-1564.
8. Gluck, M. R., Jayatilleke, E., Shaw, S., Rowan, A. J., and Haroutunian, V. 2000. CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy. Epilepsy Res. 39:63-71.
9. Milatovic, D., Gupta, R. C., and Dettbarn, W. D. 2002. Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res. 957:330-337.
10. Jarrard, L. E. 2002. Use of excitotoxins to lesion the hippocampus: Update. Hippocampus 12:405-414.
11. Candelario-Jalil, E., Al-Dalain, S. M., Castillo, R., Martinez, G., and Fernandez, O. S. 2001. Selective vulnerability to kainate-induced oxidative damage in different rat brain regions. J. Appl. Toxicol. 21:403-407.
12. Dawson, R. Jr., Beal, M. F., Bondy, S. C., Di Monte, D. A., and Isom, G.E. 1995. Excitotoxins, aging, and environmental neurotoxins: Implications for understanding human neurodegenerative diseases. Toxicol. Appl. Pharmacol. 134:1-17.
13. Miller, N. J. and Rice-Evans, C. A. 1995. Antioxidant activity of resveratrol in red wine. Clin. Chem. 41:1789.
14. Fremont, L. 2000. Biological effects of resveratrol. Life Sci. 66:663-673.
15. Sun, A. Y., Simonyi, A., and Sun, G. Y. 2002. The "French Paradox" and beyond: Neuroprotective effects of polyphenols. Free Radic. Biol. Med. 32:314-318.
16. Chanvitayapongs, S., Draczynska-Lusiak, B., and Sun, A. Y. 1997. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 8:1499-1502.
17. Bastianetto, S., Zheng, W. H., and Quirion, R. 2000. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br. J. Pharmacol. 131:711-720.
18. Jang, J. H. and Surh, Y. J. 2001. Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat. Res. 496:181-190.
19. Gupta, Y. K., Briyal, S., and Chaudhary, G. 2002. Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol. Biochem. Behav. 71:245-249.
20. Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, A., Lubahn, D., Sun, G. Y., and Sun, A. Y. 2002. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958:439-447.
21. Streit, W. J. 1990. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia GSA I-B4. J. Histochem. Cytochem. 38:1683-1686.
22. Berger, R., and Garnier, Y. 1999. Pathophysiology of perinatal brain damage. Brain Res. Brain Res. Rev. 30:107-134.
23. Shen, W., Zhang, C., and Zhang, G. 2002. Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus. Brain Res. 933:23-30.
24. Hikiji, M., Tomita, H., Ono, M., Fujiwara, Y., and Akiyama, K. 1993. Increase of kainate receptor mRNA in the hippocampal CA3 of amygdala-kindled rats detected by in situ hybridization. Life Sci. 53:857-864.
25. Lewen, A., Matz, P., and Chan, P. H. 2000. Free radical pathways in CNS injury. J. Neurotrauma 17:871-890.
26. Sun, A. Y., Cheng, Y., Bu, Q., and Oldfield, F. 1992. The biochemical mechanisms of the excitotoxicity of kainic acid. Free radical formation. Mol. Chem. Neuropath. 17:51-63.
27. Aschner, M. 1998. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 19:269-281.
28. Zhang, W., Smith, C., Howlett, C., and Stanimirovic, D. 2000. Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta. J. Cereb. Blood Flow Metab. 20:967-978.
29. Li, W., Xia, J., and Sun, G. Y. 1999. Cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC): response to genistein and pyrrolidine dithiocarbamate. J. Interferon Cytokine Res. 19:121-127.
30. Calabrese, V., Copani, A., Testa, D., Ravagna, A., Spadaro, F., Tendi, E., Nicoletti, V. G., and Giuffrida Stella, A. M. 2000. Nitric oxide synthase induction in astroglial cell cultures: effect on heat shock protein 70 synthesis and oxidant/antioxidant balance. J. Neurosci. Res. 60:613-622.
31. Akama, K.T. and Van Eldik, L. J. 2000. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1 beta- and tumor necrosis factor alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factorand NFkappaB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275:7918-7924.
32. Kyrkanides, S., Moore, A. H., Olschowka, J. A., Daeschner, J. C., Williams, J. P., Hansen, J. T., and O'Banion, M. K. 2002. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Mol. Brain Res. 104:159-169.
33. Dorandeu, F., Pernot-Marino, I., Veyret, J., Perrichon, C., and Lallement, G. 1998. Secreted phospholipase A2-induced neurotoxicity and epileptic seizures after intracerebral administration: an unexplained heterogeneity as emphasized with paradoxin and crotoxin. J. Neurosci. Res. 54:848-862.
34. Wang, J. H. and Sun, G. Y. 2000. Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC). Neurochem. Res. 25:613-619.
35. Xu, J., Weng, Y., Simonyi, A., Krugh, B. W., Liao, Z., Weisman, G. A., and Sun, G. Y. 2002. Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachidonic acid release in primary murine astrocytes. J. Neurochem. 83:259-270.
36. Xu, J., Yu, S., Sun, A. Y., and Sun, G. Y. 2003. Oxidant-mediated AA Release from astrocytes involves cPLA2 and iPLA2. Free Radic. Biol. Med. 34:1531-1543.
37. Farooqui, A. A., Yang, H. C., Rosenberger, T. A., and Horrocks, L. A. 1997. Phospholipase A-2 and its role in brain tissue. J. Neurochem. 69:889-901.
38. Farooqui, A. A., Yi Ong, W., Lu, X. R., Halliwell, B., and Horrocks, L. A. 2001. Neurochemical consequences of kainate-induced toxicity in brain: Involvement of arachidonic acid release and prevention of toxicity by phospholipase A(2) inhibitors. Brain Res. Rev. 38:61-78.
39. Unger, J. W. 1998. Glial reaction in aging and Alzheimer's disease. Microsc. Res. Tech. 43:24-28.
40. Sheng, J. G., Griffin, W. S. T., Royston, M. C., and Mrak, R. E. 1998. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: Implication for neuritic plaque formation in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 24:278-283.
41. Wu, D. C., Tieu, K., Cohen, O., Choi, D. K., Vila, M., Jackson-Lewis, V., Teismann, P., and Przedborski, S. 2002. Glial cell response: A pathogenic factor in Parkinson's disease. J. Neurovirol. 8:551-558.
42. Mouton, P. R., Long, J. M., Lei, D-L., Howard, V., Jucker, M., Calhoun, M. E., and Ingram, D. K. 2002. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res. 956:30-35.
43. Yu, W. H., Go, L., Guinn, B. A., Fraser, P. E., Westaway, D., and McLaurin, J. 2002. Phenotypic and functional changes in glial cells as a function of age. Neurobiol. Aging. 23:105-115.
44. Zini, R., Morin, C., Bertelli, A., Bertelli, A. A. E., and Tillement, J-P. 1999. Effects of resveratrol on the rat brain respiratory chain. Drugs Under Exp. Clin. Res. 25:87-97.
45. Tadolini, B., Juliano, C., Piu, L, Franconi, F., and Cabrini L. 2000. Resveratrol inhibition of lipid peroxidation. Free Radic. Res. 33:105-114.
46. Mizutani, K., Ikeda, K., Kawai, Y., and Yamori, Y. 2001. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 28:55-59.
47. Win, W., Cao, Z., Peng, X., Trush, M. A., and Li, Y. 2002. Different effects of genistein and resveratrol on oxidative DNA damage in vitro. Mutat. Res. 513:113-120.
48. Draczynska-Lusiak, B., Doung, A., and Sun, A. Y. 1998. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease. Mol. Chem. Neuropathol. 33:139-148.
49. Draczynska-Lusiak, B., Chen, Y. M., and Sun, A. Y. 1998. Oxidized lipoproteins activate NF-kappaB binding activity and apoptosis in PC12 cells. NeuroReport 9:527-532.
50. Sun, A. Y., Chen, Y. M., James-Kracke, M., Wixom, P., and Cheng, Y. 1997. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem. Res. 22:1187-1192.
51. Sun, A. Y. and Sun, G. Y. 2001. Ethanol and oxidative mechanisms in the brain. J. Biomed. Sci. 8:37-43.
52. Sun, A. Y., Ingelman-Sundberg, M., Neve, E., Matsumoto, H., Nishitani, Y., Minowa, Y., Fukui, Y., Bailey, S. M., Patel, V. B., Cunningham, C. C., Zima, T., Fialova, L., Mikulikova, L., Popov, P., Malbohan, I., Janebova, M., Nespor, K., and Sun, G. Y. 2001. Ethanol and oxidative stress. Alcoholism: Clin. Exp. Res. 25:237S-243S.